2012
DOI: 10.3892/etm.2012.574
|View full text |Cite
|
Sign up to set email alerts
|

Vascular regeneration by pinpoint delivery of growth factors using a microcatheter reservoir system in a rabbit hind-limb ischemia model

Abstract: Abstract. The purpose of this study was to compare the results of delivering low doses of growth factor iteratively (20 µg x5) via a reservoir system with results obtained following a single administration of 100 µg of growth factor. The delivery systems using gelatin microspheres (GMS) facilitate the controlled release of drugs. The controlled release of growth factors at specific sites is essential for vascular regeneration. An ischemic hind-limb model was established in nine rabbits. A reservoir system was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 23 publications
(31 reference statements)
1
1
0
Order By: Relevance
“…This finding is in contrast to multiple studies that have found enhancement of revascularization in the ischemic hindlimbs of healthy rabbits using FGF-2. [25][26][27][28][29][30][31][32] The results from the advanced rabbit model are consistent with the lack of efficacy for FGF-2 treatments in clinical trials for intermittent claudication 8 and suggests that the optimized rabbit model may provide better correlation with clinical outcomes.…”
Section: Discussionsupporting
confidence: 58%
“…This finding is in contrast to multiple studies that have found enhancement of revascularization in the ischemic hindlimbs of healthy rabbits using FGF-2. [25][26][27][28][29][30][31][32] The results from the advanced rabbit model are consistent with the lack of efficacy for FGF-2 treatments in clinical trials for intermittent claudication 8 and suggests that the optimized rabbit model may provide better correlation with clinical outcomes.…”
Section: Discussionsupporting
confidence: 58%
“…Furthermore, bFGF activates in vivo the plasminogen activator (Presta et al, 1986), facilitating migration and proliferation of vascular endothelial cells by dissolution of the vascular basement membrane (Gospodarowicz et al, 1987). It also promotes in vivo the revascularization, tubule formation, and capillary regeneration (Folkman and Klagsbrun, 1987;Saksela et al, 1987) and the formation of granulation tissue (Okumura et al, 1996), enhancing the collateral blood flow in a rabbit hindlimb ischemic model (Nitta et al, 2012), and inducing cartilage in a model of auricular cartilage defect (Morotomi et al, 2012). Finally, the enhancement of the proliferation and differentiation of mesenchymal stem cells by bFGF has been demonstrated to promote fracture healing (Kawaguchi, 2009).…”
Section: Introductionmentioning
confidence: 99%